Original article Suyeon Jo, Byoungkuk Kim, Boyeong Kwon, Kwanghyun Kim, Minhyeok Kim, Kihyung Park Department of Laboratory Medicine, Seegene Medical Foundation, Busan, Korea Correspondence to Suyeon Jo E-mail: freedom96@naver.com; Kihyung Park E-mail: p0413@mf.seegene.com Ann Clin Microbiol 2026;29(1):4. https://doi.org/10.5145/ACM.2026.29.1.4Received on 12 January 2026, Revised on 26 February 2026, Accepted on 27 February 2026, Published on 11 March 2026.Copyright © Korean Society of Clinical Microbiology.This is an Open Access article which is freely available under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/). Abstract Background: Pathogenic Escherichia coli (PEC) is a leading cause of acute diarrhea worldwide. With increasing antibiotic use, antimicrobial resistance in PEC has become a significant public health concern. In this study, we investigated the distribution and antimicrobial susceptibility patterns of PEC isolated from patients with acute diarrhea in the Busan and Gyeongnam regions of South Korea. Methods: In this retrospective cross-sectional laboratory-based study, 272 PCR-positive residual

Original article Jeong Su Park1*, Kyu-Hwa Hur2*, Woo Jin Shin1, Hyunji Kim1, Dong Woo Shin1, Kyoung Un Park1 1Department of Laboratory Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea2Department of Laboratory Medicine, Green Cross Laboratories, Yongin, Korea*These authors contributed equally to this work. Correspondence to Jeong Su Park, E-mail: mdmicrobe@gmail.com Ann Clin Microbiol 2025;28(4):24. https://doi.org/10.5145/ACM.2025.28.4.5Received on 12 November 2025, Revised on 10 December 2025, Accepted on 10 December 2025, Published on 20 December 2025.Copyright © Korean Society of Clinical Microbiology.This is an Open Access article which is freely available under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/). Abstract Background: Mycobacterium avium complex (MAC) is a major cause of pulmonary nontuberculous mycobacterial disease; however, treatment outcomes remain suboptimal. Phenotypic drug susceptibility testing (DST) is conditionally recommended; however, conventional broth microdilution is labor-intensive. The Sensititre SLOMYCO® panel offers a standardized platform for DST

Original article Eun-Young Kim1, Yeon Chan Choi1, Hyeon Jin Choi1, Si Hyun Kim2, Jihyun Cho3, Seok Hoon Jeong4, Dokyun Kim4, Hyun Soo Kim5, Soo Hyun Kim6, Young Ah Kim7, Young Ree Kim8, Nam Hee Ryoo9, Jong Hee Shin6, Kyeong Seob Shin10, Young Uh11, Jeong Hwan Shin1 1Department of Laboratory Medicine and Paik Institute for Clinical Research, Inje University College of Medicine, Busan, Korea2Department of Biomedical Laboratory Science, Inje University, Gimhae, Korea.3Department of Laboratory Medicine, Wonkwang University Medical School, Iksan, Korea4Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea5Department of Laboratory Medicine, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Korea6Department of Laboratory Medicine, Chonnam National University Medical School, Gwangju, Korea7Department of Laboratory Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Korea8Department of Laboratory Medicine, Jeju National University College of Medicine, Jeju, Korea9Department of Laboratory Medicine, Keimyung University School

Review article Ha-eun Cho1, Young Jin Kim2 1Department of Laboratory Medicine, Kyung Hee University Hospital, Seoul, Korea2Department of Laboratory Medicine, Kyung Hee University College of Medicine, Kyung Hee University Hospital, Seoul, Korea Correspondence to Young Jin Kim, E-mail: khmclab@gmail.com Ann Clin Microbiol 2025;28(3):17. https://doi.org/10.5145/ACM.2025.28.3.6Received on 7 July 2025, Revised on 4 September 2025, Accepted on 4 September 2025, Published on 20 September 2025.Copyright © Korean Society of Clinical Microbiology.This is an Open Access article which is freely available under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/). Abstract Latent tuberculosis infection refers to a state in which an individual is infected with Mycobacterium tuberculosis but shows no clinical symptoms. The World Health Organization estimates that 23-25% of the global population has LTBI, which poses a significant public health challenge owing to the risk of progression to active TB. Diagnosis of LTBI involves tests, such as the tuberculin skin test

Original article Harshad Lade1*, Tae-Im Kim1*, Jung-Min Kim1, Yong-Kyun Kim2, Kibum Jeon3, Hyun Soo Kim4, Han-Sung Kim5, Wonkeun Song6, Jae-Seok Kim1 1Department of Laboratory Medicine, Hallym University College of Medicine, Kangdong Sacred Heart Hospital, Seoul, Korea2Department of Laboratory Medicine, Sahmyook Medical Center, Seoul, Korea3Department of Laboratory Medicine, Hallym University College of Medicine, Hangang Sacred Heart Hospital, Seoul, Korea4Department of Laboratory Medicine, Hallym University College of Medicine, Dongtan Sacred Heart Hospital, Hwaseong, Korea5Department of Laboratory Medicine, Hallym University College of Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea6Department of Laboratory Medicine, Hallym University College of Medicine, Kangnam Sacred Heart Hospital, Seoul, Korea *These authors contributed equally to this work. Correspondence to Jae-Seok Kim, E-mail: jaeseok@kdh.or.kr Ann Clin Microbiol 2025;28(3):15. https://doi.org/10.5145/ACM.2025.28.3.4Received on 23 May 2025, Revised on 20 June 2025, Accepted on 30 June 2025, Published on 10 September 2025.Copyright © Korean Society of Clinical Microbiology.This is an Open Access article which

Review article Hyun Joo Jung Department of Pediatrics, Ajou University School of Medicine, Ajou University Hospital, Suwon, Korea Correspondence to Hyun Joo Jung, E-mail: free1109@ajou.ac.kr This article is a secondary publication of the original work published in Korean in the Korean Journal of Healthcare-associated Infection Control and Prevention (2024;29(2):110–115, https://doi.org/10.14192/kjicp.2024.29.2.110). This English version has been translated and published in Annals of Clinical Microbiology with the permission of the editors of both the Korean Journal of Healthcare-associated Infection Control and Prevention and the Annals of Clinical Microbiology. This secondary publication complies with the conditions set forth in the “Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals” by the International Committee of Medical Journal Editors (ICMJE), and serves to enhance accessibility and value by making the content available to a broader international readership through English translation. Ann Clin Microbiol 2025;28(2):8. https://doi.org/10.5145/ACM.2025.28.2.2Received on 15 May 2025, Revised